Janney Montgomery Scott
FLGT icon

Janney Montgomery Scott’s Fulgent Genetics FLGT Stock Holding History

Janney Montgomery Scott’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,393
Closed -$296K – 2533
2022
Q2 		$296K Buy
5,393
+1,976
+58% +$109K ﹤0.01% 1925
2022
Q1 		$213K Buy
+3,417
New +$225K ﹤0.01% 2050
2021
Q1 		– Sell
-10,100
Closed -$526K – 2286
2020
Q4 		$526K Buy
+10,100
New +$422K ﹤0.01% 1543

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Janney Montgomery Scott's FLGT Position: Q3 2022 in Review

Janney Montgomery Scott sold out of Fulgent Genetics (FLGT) in Q3 2022, closing a stake of 5,393 shares — an estimated $296K sold.

Janney Montgomery Scott first reported a position in FLGT in Q4 2020 and held it in 3 quarters. The position peaked at $526K in Q4 2020. 235 funds tracked by Wall St. Rank hold FLGT as of Q3 2022.

  • Janney Montgomery Scott reported no remaining Fulgent Genetics position as of Q3 2022 after selling out during the quarter.
  • Janney Montgomery Scott sold 5,393 Fulgent Genetics shares in Q3 2022, an estimated $296K.
  • Janney Montgomery Scott first reported a position in Fulgent Genetics in Q4 2020 and held it in 3 quarters.
  • Janney Montgomery Scott's Fulgent Genetics position peaked at $526K in Q4 2020.
  • 235 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2022.

Based on Janney Montgomery Scott's 13F filing for Q3 2022, filed 25 Oct 2022.